JPMORGAN CHASE & CO - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$8,371,433
-13.8%
327,649
-3.2%
0.00%0.0%
Q2 2023$9,708,811
+18.5%
338,522
-1.0%
0.00%0.0%
Q1 2023$8,193,000
+140673.2%
341,840
-0.4%
0.00%0.0%
Q4 2022$5,820
-99.9%
343,177
-0.9%
0.00%0.0%
Q3 2022$5,130,000
+0.3%
346,151
+6.5%
0.00%0.0%
Q2 2022$5,116,000
-41.6%
325,060
-0.0%
0.00%0.0%
Q1 2022$8,766,000
-33.2%
325,135
-8.3%
0.00%
-50.0%
Q4 2021$13,122,000
+17.5%
354,577
+51.6%
0.00%
+100.0%
Q3 2021$11,172,000
+24.2%
233,833
-12.0%
0.00%0.0%
Q2 2021$8,993,000
-10.0%
265,750
+9.8%
0.00%0.0%
Q1 2021$9,997,000
+93.9%
242,060
+103.7%
0.00%0.0%
Q4 2020$5,156,000
+177.5%
118,853
+173.4%
0.00%
Q3 2020$1,858,000
+16.4%
43,472
+27.3%
0.00%
Q2 2020$1,596,000
+454.2%
34,152
+61.4%
0.00%
Q1 2020$288,000
-58.7%
21,156
-67.0%
0.00%
Q4 2019$698,000
+46.6%
64,169
+38.5%
0.00%
Q3 2019$476,000
+271.9%
46,344
+249.9%
0.00%
Q2 2019$128,00013,2450.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders